| AXG 0.04 -25.65% | SHFS 0.1158 23.19% | DVLT 0.067 -49.55% | XXII 0.1048 18.55% | NEXR 0.5454 21.77% | SOFI 16.4 13.42% | WFF 0.0601 -33.07% | NU 12.4 -1.51% | NVD 3.93 -1.50% | SPCX 148.58 1.14% | SOXL 101.08 11.69% | EWZ 34.3 0.45% | INTC 93.74 3.61% | NVDA 217.94 0.90% | BBD 2.91 -0.51% | SOXS 42.5 -11.42% | GPUS 0.2126 19.10% | JBLU 2.82 18.99% | GRAB 2.72 0.37% | NOK 8.89 3.30% | VALE 11.84 -1.33% | SNTI 0.1867 6.62% | AAL 12.61 3.36% | HYG 77.6 0.52% | BITO 10.79 1.27% | CRWV 59.57 7.94% | TSLL 11.63 8.09% | RCT 0.0656 -20.68% | META 620.19 -1.64% | TQQQ 71.04 3.81% | QID 13.86 -2.53% | STLA 4.14 1.47% | NFLX 62.52 -2.16% | TSLG 5.82 8.18% | ONDS 6.65 7.95% | BA 168.18 -10.69% | IREN 27.44 7.90% | T 20.94 0.46% | BRAI 3.31 56.13% | PLUG 1.4 2.19% | TSLA 407.46 4.04% | CIFR 8.48 9.99% | RIG 6.46 -1.07% | F 11.71 1.12% | RWM 14.34 -1.10% | XP 15.96 1.62% | KORU 11.86 8.91% | AAPL 347.1 0.93% | ITUB 7.67 -0.39% | SNAP 6.06 -4.42%

GSK Sales Get Boost From Specialty Medicines

The U.K. drugmaker's strength in the segment allowed it to offset a declining vaccines revenue and a flat performance in general medicines.

TC Trade Conquest Newsroom October 28, 2026 ·1 min read

GSK Sales Get Boost From Specialty Medicines

The U.K. drugmaker's strength in the segment allowed it to offset a declining vaccines revenue and a flat performance in general medicines.

See the latest quote, chart and news for GSK.

Read the full story at wsj.com ↗

Want trade ideas like this in real time? Subscribe to Trade Conquest.

More news